About this item:

24 Views | 11 Downloads

Author Notes:

Mary Jo Lechowicz, Email: mlechow@emory.edu

None disclosed.

Subjects:

Research Funding:

None.

Keywords:

  • CTCL
  • CTCL, cutaneous T-cell lymphoma
  • RCC, renal cell carcinoma
  • Sezary syndrome
  • adverse events
  • immune checkpoint inhibitor
  • mycosis fungoides
  • nivolumab

Nivolumab-associated cutaneous T-cell lymphoma

Tools:

Journal Title:

JAAD Case Reports

Volume:

Volume 9

Publisher:

, Pages 39-41

Type of Work:

Article | Final Publisher PDF

Copyright information:

© 2021 by the American Academy of Dermatology, Inc.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/rdf).
Export to EndNote